Cargando…
The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a distinct eosinophilic phenotype of severe asthma with accompanying chronic rhinosinusitis, nasal polyposis, and hypersensitivity to aspirin. Urinary 3-bromotyrosine (uBrTyr) is a noninvasive marker of eosinophil-catalyzed protein oxidat...
Autores principales: | Comhair, Suzy A. A., Bochenek, Grazyna, Baicker-McKee, Sara, Wang, Zeneng, Stachura, Tomasz, Sanak, Marek, Hammel, Jeffrey P., Hazen, Stanley L., Erzurum, Serpil C., Nizankowska-Mogilnicka, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208044/ https://www.ncbi.nlm.nih.gov/pubmed/30376852 http://dx.doi.org/10.1186/s12931-018-0909-6 |
Ejemplares similares
-
Co-Occurrence of Asthma and Nephrolithiasis in Children
por: Kartha, Ganesh K., et al.
Publicado: (2017) -
Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021) -
Complement C3 Deficiency Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in Mice
por: Bauer, Eileen M., et al.
Publicado: (2011) -
Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension
por: Farha, Samar, et al.
Publicado: (2016) -
Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension
por: Duong, Heng T., et al.
Publicado: (2011)